We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $1.67B
1-Year Est. Return 1.43%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
-1.43%
3 Year Est. Return
-6.61%
5 Year Est. Return
-27.23%
10 Year Est. Return
AUM
$1.67B
AUM Growth
-$505M
Cap. Flow
-$520M
Cap. Flow %
-31.03%
Top 10 Hldgs %
29.21%
Holding
171
New
21
Increased
23
Reduced
68
Closed
55

Top Sells

Rank Stock Value
1
CHRD icon
Chord Energy
CHRD
+$73.2M
2
TFX icon
Teleflex
TFX
+$52.2M
3
AKAM icon
Akamai
AKAM
+$46.6M
4
RNG icon
RingCentral
RNG
+$30.2M
5
HAE icon
Haemonetics
HAE
+$28.8M

Sector Composition

Rank Sector Weight
1 Technology 32.19%
2 Healthcare 19.57%
3 Industrials 14.44%
4 Consumer Discretionary 10.33%
5 Communication Services 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNDY icon
26
monday.com
MNDY
$4.26B
$21M 1.26%
290,707
+90,190
+45% +$6.61M
INGR icon
27
Ingredion
INGR
$6.6B
$20.9M 1.25%
220,493
-40,178
-15% -$4.25M
UPWK icon
28
Upwork
UPWK
$1.13B
$20.1M 1.2%
2,406,922
+492,421
+26% +$4.66M
HURN icon
29
Huron Consulting
HURN
$2.54B
$19.8M 1.19%
+220,073
New +$25.2M
DOLE icon
30
Dole
DOLE
$1.3B
$19.6M 1.17%
1,430,966
-329,343
-19% -$4.79M
PATH icon
31
UiPath
PATH
$9.4B
$19.4M 1.16%
1,787,590
+150,688
+9% +$1.61M
FIVN icon
32
FIVE9
FIVN
$2.54B
$19M 1.14%
892,658
-44,130
-5% -$871K
DLO icon
33
dLocal
DLO
$4.42B
$18.1M 1.08%
1,395,170
+1,139,818
+446% +$14.5M
PRGS icon
34
Progress Software
PRGS
$1.84B
$17.2M 1.03%
+511,240
New +$15.1M
LZ icon
35
LegalZoom.com
LZ
$1.05B
$16.4M 0.98%
2,676,821
-247,780
-8% -$1.52M
HAE icon
36
Haemonetics
HAE
$4.73B
$16.2M 0.97%
216,217
-448,512
-67% -$28.8M
ENOV icon
37
Enovis
ENOV
$1.44B
$16M 0.95%
772,034
-131,428
-15% -$3.1M
TNC icon
38
Tennant Co
TNC
$1.19B
$16M 0.95%
182,387
-167,005
-48% -$13.9M
COUR icon
39
Coursera
COUR
$1.71B
$15.8M 0.94%
2,798,362
-752,364
-21% -$4.27M
PENN icon
40
PENN Entertainment
PENN
$2.33B
$15.8M 0.94%
738,495
-806,272
-52% -$14.4M
CMCSA icon
41
Comcast
CMCSA
$96B
$15.5M 0.92%
629,808
+542,298
+620% +$14M
ZBH icon
42
Zimmer Biomet
ZBH
$19.2B
$15.4M 0.92%
178,691
+8,985
+5% +$788K
GEN icon
43
Gen Digital
GEN
$18.6B
$15.2M 0.91%
610,309
+347,374
+132% +$7.76M
GEHC icon
44
GE HealthCare
GEHC
$32.4B
$14.9M 0.89%
+233,035
New +$15.3M
PRU icon
45
Prudential Financial
PRU
$41.3B
$14.6M 0.87%
135,381
+15,730
+13% +$1.6M
KBR icon
46
KBR
KBR
$4.79B
$12.8M 0.76%
+369,476
New +$12.9M
RYZ
47
Ryerson Holding Corp
RYZ
$1.31B
$12.5M 0.75%
508,048
-136,236
-21% -$3.6M
CHWY icon
48
Chewy
CHWY
$9.52B
$12.1M 0.72%
+613,972
New +$13.9M
CXT icon
49
Crane NXT
CXT
$2.89B
$12M 0.71%
233,914
+85,733
+58% +$3.66M
MDT icon
50
Medtronic
MDT
$117B
$11.9M 0.71%
+152,330
New +$12.3M

Similar funds

Invenomic Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Invenomic Capital Management held 171 positions worth $1.67B, down 23% from $2.18B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Invenomic Capital Management withdrew a net $520M in Q2 2026, closing 55 positions and reducing 68 holdings. Its most notable exit was Chord Energy, an estimated $73.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Invenomic Capital Management opened a new position in Charter Communications worth $40.2M.

  • Invenomic Capital Management's largest Q2 2026 buy was Charter Communications: 282,416 shares worth $40.2M.
  • Invenomic Capital Management added most to Universal Health Services in Q2 2026, an estimated $39.4M increase.
  • Invenomic Capital Management's biggest Q2 2026 reduction was Haemonetics, cutting an estimated $28.8M.
  • Invenomic Capital Management fully exited Chord Energy in Q2 2026, selling an estimated $73.2M.
  • Invenomic Capital Management's ten largest holdings make up 29% of its $1.67B portfolio in Q2 2026.
  • Invenomic Capital Management opened 21 new positions and closed 55 in Q2 2026.
  • Invenomic Capital Management's portfolio value fell 23% quarter-over-quarter to $1.67B.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.